These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9820578)

  • 1. Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group.
    Demeter LM; D'Aquila R; Weislow O; Lorenzo E; Erice A; Fitzgibbon J; Shafer R; Richman D; Howard TM; Zhao Y; Fisher E; Huang D; Mayers D; Sylvester S; Arens M; Sannerud K; Rasheed S; Johnson V; Kuritzkes D; Reichelderfer P; Japour A
    J Virol Methods; 1998 Nov; 75(1):93-104. PubMed ID: 9820578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.
    Shafer RW; Hertogs K; Zolopa AR; Warford A; Bloor S; Betts BJ; Merigan TC; Harrigan R; Larder BA
    J Clin Microbiol; 2001 Apr; 39(4):1522-9. PubMed ID: 11283081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase.
    Hanna GJ; Johnson VA; Kuritzkes DR; Richman DD; Martinez-Picado J; Sutton L; Hazelwood JD; D'Aquila RT
    J Clin Microbiol; 2000 Jul; 38(7):2715-21. PubMed ID: 10878069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group.
    Shafer RW; Winters MA; Mayers DL; Japour AJ; Kuritzkes DR; Weislow OS; White F; Erice A; Sannerud KJ; Iversen A; Pena F; Dimitrov D; Frenkel LM; Reichelderfer PS
    J Clin Microbiol; 1996 Jul; 34(7):1849-53. PubMed ID: 8784610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.
    Schuurman R; Demeter L; Reichelderfer P; Tijnagel J; de Groot T; Boucher C
    J Clin Microbiol; 1999 Jul; 37(7):2291-6. PubMed ID: 10364600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations.
    Schmit JC; Ruiz L; Stuyver L; Van Laethem K; Vanderlinden I; Puig T; Rossau R; Desmyter J; De Clercq E; Clotet B; Vandamme AM
    J Virol Methods; 1998 Jul; 73(1):77-82. PubMed ID: 9705178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.
    Galli RA; Sattha B; Wynhoven B; O'Shaughnessy MV; Harrigan PR
    J Clin Microbiol; 2003 Jul; 41(7):2900-7. PubMed ID: 12843019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
    Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analogues.
    Clarke JR; Kaye S; Babiker AG; Hooker MH; Tedder R; Weber JN
    J Virol Methods; 2000 Aug; 88(2):117-24. PubMed ID: 10960699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
    Trabaud MA; Leriche-Guerin K; Regis C; Bordes I; Cotte L; Detmer J; Kolberg J; Ritter J; Trépo C
    J Med Virol; 2000 Jul; 61(3):352-9. PubMed ID: 10861645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction.
    Anderson BD; Shirasaka T; Kojima E; Yarchoan R; Mitsuya H
    Antiviral Res; 1994 Dec; 25(3-4):245-58. PubMed ID: 7710271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional mutations detected in sequential HIV-1 isolates from ZDV-treated patients.
    Magierowska-Jung M; Agut H; Katlama C; Autran B; Huraux JM
    J Med Virol; 1997 Jan; 51(1):48-55. PubMed ID: 8986949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the editing process in human immunodeficiency virus type 1 genotyping.
    Huang DD; Eshleman SH; Brambilla DJ; Palumbo PE; Bremer JW
    J Clin Microbiol; 2003 Jul; 41(7):3265-72. PubMed ID: 12843074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group.
    Mayers D; Bethel J; Wainberg MA; Weislow O; Schnittman S
    J Infect Dis; 1998 Jun; 177(6):1730-3. PubMed ID: 9607859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of the HIV type 1 reverse transcriptase codon T215Y by reverse transcription-polymerase chain reaction with fluorogenic probes.
    Ross L; Vavro C; Zimmermann A; St Clair M
    AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1287-92. PubMed ID: 10505677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective vertical transmission of HIV-1 antiretroviral resistance mutations.
    Colgrove RC; Pitt J; Chung PH; Welles SL; Japour AJ
    AIDS; 1998 Dec; 12(17):2281-8. PubMed ID: 9863870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZT-related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus type 1 confers decrease in susceptibility to ddATP in in vitro RT inhibition assay.
    Sharma PL; Chatis PA; Dogon AL; Mayers DL; McCutchan FE; Page C; Crumpacker CS
    Virology; 1996 Sep; 223(2):365-9. PubMed ID: 8806572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.
    Kaye S; Comber E; Tenant-Flowers M; Loveday C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1221-5. PubMed ID: 8573378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
    Reinis M; Vandasová J; Stanková M; Linka M; Brůcková M
    Acta Virol; 2001; 45(5-6):279-86. PubMed ID: 12083326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence analysis of proviral HIV RT amplified directly by a semi-quantitative technique from AZT treated patients.
    Stein CA; Levantis P; Oxford JS
    J Med Virol; 1994 Oct; 44(2):115-21. PubMed ID: 7531752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.